The nation of Zimbabwe has rejected a significant US health deal worth $367m (272 million pounds) over five years because of the United States' demand for confidential data.
The decision came to light after a official document dated December was leaked, indicating that Head of State Emmerson Mnangagwa deemed the agreement was "skewed".
An official spokesman has since explained that the US was requesting genetic material for research and commercial gain while was not willing to guarantee the benefits from any future vaccines.
"We will now turn to the difficult and regrettable task of scaling back our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the United States had furnished more than $1.9bn for health programmes to Zimbabwe during the past twenty years.
A physicians' group in Zimbabwe has urged continued talks to secure a deal acceptable to both sides so the nation's vital HIV treatment initiative can be sustained.
Wider Background
This development comes after a comparable case in Kenya, where a court blocked a related health funding agreement following concerns were raised about the safety of Kenyans' medical information.
Since returning to the presidency recently, US President Donald Trump has reduced foreign aid and shut down the key foreign aid agency.
USAID had overseen aid for the American government, but Trump claimed its spending was "wasteful" and his administration was seeking government-to-government deals to boost openness and accountability.
Based on reports, Sixteen African countries have so far signed similar agreements, representing more than $18.3bn of fresh investment.
Details of the Rejected Deal
This assistance for Zimbabwe would have funded "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this collaboration could have provided significant advantages for Zimbabwean communities, especially the 1.2 million currently on HIV treatment via American-funded programmes," Tremont said.
However, official spokesman Nick Mangwana maintained the proposed deal was "unfair".
"Zimbabwe was being asked to surrender its genetic material and health information over an extended period, with no equivalent assurance of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could be developed from that shared data," he stated.
"Effectively, our nation would provide the basic resources for medical research without any certainty that the resulting innovations would be available to our citizens if a future pandemic emerge."
National Interest and International Frameworks
Mangwana further pointed out that the US's withdrawal from the global health body and its push of bilateral deals were disrupting frameworks already established through the international organization.
Mangwana cited its Pandemic Benefit-Sharing scheme created to deal with potential global health emergencies.
"This framework is intended to ensure that when a nation contributes its samples, the resulting advantages – including medicines and cures – are shared equitably, not monopolised solely by those with the resources to develop them."
Zimbabwe's reservations regarding the US deal "must not be interpreted as opposition to America," Mangwana stressed.
"We are open to continued discussions with our US partners on how future collaboration might be structured in a way that respects the independence and interests of both nations."
Medical Community Response
A leading public health body stated it recognised the government's concerns, but suggested that negotiations should continue considering a large portion of the nation's HIV programmes were funded by foreign aid.
"Where specific concerns arise, including those involving information security or implementation frameworks, these can frequently be resolved through detailed discussion and mutually agreed protections," the group said.
The halted deal emphasises the continuing challenges between receiving vital international aid and protecting national sovereignty in an increasingly interconnected world.